Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...

By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of fighting cancer.

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of an array of ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

The project will initially be launched at the Pak­is­tan Institute of Medical Sciences (Pims) in Isla­m­abad, and will be expanded based on performance. Under the agreement, thousands of eligible ...

WASHINGTON D.C., DC — Two bills aimed at expanding life-saving cancer treatments for children remain stalled in Congress, ...